Registration NO:鄂械注准20252405439
Used for in vitro quantitative detection of the content of neutrophil gelatinase-associated lipocalin in human urine.
【Clinical significance】
NGAL is an early marker for detecting kidney disease, especially acute kidney injury (AKI). It is used for auxiliary diagnosis of renal function damage.
【Application scenarios】
Community hospitals, third-party medical institutions, nephrology, endocrinology and diabetes departments, etc.
【Reference range】
<130ng/mL.
【Intended use】
Used for in vitro quantitative detection of the content of neutrophil gelatinase-associated lipocalin in human urine.
【Product registration certificate number】
E (Wu) Medical Device Registration No. 20252405439
【Manufacturer】
Wuhan Xurui Biotech Co., Ltd.